PAX2 Regulates ADAM10 Expression and Affects Melanoma Cell Growth
Author Information
Author(s): Lee Sophia Boyoung, Doberstein Kai, Baumgarten Peter, Wieland Anja, Ungerer Christopher, Bürger Claudia, Hardt Katja, Boehncke Wolf-Henning, Pfeilschifter Josef, Mihic-Probst Daniela, Mittelbronn Michel, Gutwein Paul
Primary Institution: Pharmazentrum Frankfurt/ZAFES, University Hospital Goethe University Frankfurt, Frankfurt am Main, Germany
Hypothesis
PAX2 plays a significant role in the regulation of ADAM10 expression and melanoma progression.
Conclusion
PAX2 is involved in melanoma cell growth, migration, invasion, and chemoresistance, making it a potential therapeutic target.
Supporting Evidence
- PAX2 expression was found to be weak in normal melanocytes but increased in melanoma cells.
- Downregulation of PAX2 inhibited anchorage-independent growth of melanoma cells.
- PAX2 was shown to regulate ADAM10 expression, which is important for melanoma metastasis.
- Co-expression of PAX2 and ADAM10 was observed in tissue samples from melanoma patients.
- Downregulation of PAX2 increased apoptosis in melanoma cells treated with cisplatin.
Takeaway
PAX2 helps melanoma cells grow and survive, and if we can block it, we might stop the cancer from spreading.
Methodology
The study used Western Blot, immunofluorescence, and chromatin immunoprecipitation assays to analyze PAX2 and ADAM10 expression in melanoma cells.
Limitations
The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.
Participant Demographics
The study included tissue samples from 13 patients, with 5 cases of benign nevi and 8 cases of malignant melanoma.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website